ULBI — Ultralife Cashflow Statement
0.000.00%
Last trade - 00:00- $95.73m
- $136.94m
- $164.46m
- 55
- 86
- 26
- 57
Annual cashflow statement for Ultralife, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5.33 | -0.23 | -0.12 | 7.17 | 6.41 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.053 | 0.775 | 0.812 | 0.592 | 0.951 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 12 | 0.388 | -5.45 | -11 | 3.89 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 21.7 | 4.33 | -1.26 | 1.93 | 16.6 |
| Capital Expenditures | -3.1 | -2.81 | -1.68 | -2.55 | -1.93 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.12 | -23.5 | 0 | — | -48 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -2.98 | -26.3 | -1.68 | -2.55 | -50 |
| Financing Cash Flow Items | -0.09 | -0.262 | -0.115 | -0.008 | -1.39 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -15.7 | 19.6 | 0.518 | 5.49 | 29.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.25 | -2.24 | -2.7 | 4.57 | -3.42 |